Intrinsic Value of S&P & Nasdaq Contact Us

Deciphera Pharmaceuticals, Inc. DCPH NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.32
+2.9%

Deciphera Pharmaceuticals, Inc. (DCPH) has 20 known insider and institutional holders on record. The largest holder is New Leaf Venture Management III, L.L.C. with 1,886,282 shares. Other notable holders include Hoerter Steven L. and Sherman Matthew L.

DCPH Insider Ownership

Top Holder
New Leaf Venture Management III, L.L.C.
1,886,282 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 New Leaf Venture Management Iii, L.l.c. 10 Percent Owner 1,886,282 2019-08-19
100%
2 Hoerter Steven L. President and CEO 298,100 2024-02-20
16%
3 Sherman Matthew L EVP & Chief Medical Officer 69,100 2024-02-20
4%
4 Dhanak Dashyant EVP & Chief Scientific Officer 69,100 2024-02-20
4%
5 Kelly Thomas Patrick Chief Financial Officer 69,100 2024-02-20
4%
6 Rosen Oliver Chief Medical Officer 68,500 2018-09-20
4%
7 Flynn Daniel Lee Chief Scientific Officer 57,158 2023-06-21
3%
8 Ruddy Stephen B. Chief Technical Officer 52,000 2019-02-01
3%
9 Brightstar Associates Llc 10 Percent Owner 48,136 2024-02-09
3%
10 Martin Daniel C. Chief Commercial Officer 38,900 2024-02-20
2%
11 Pitman Jama SVP, Chief Development Officer 38,900 2024-02-20
2%
12 Bristol James Arthur Director 30,000 2023-06-23
2%
13 Martin John Richard Director 30,000 2023-06-23
2%
14 Kelley Susan L. Director 30,000 2023-06-23
2%
15 Benz Edward J. Jr Director 30,000 2023-06-23
2%
16 Ratcliffe Liam 10 Percent Owner 12,000 2018-05-21
1%
17 Ross Michael Jay Director 12,000 2019-06-13
1%
18 Allen Patricia L Director 4,727 2024-01-18
0%
19 Squarer Ron Director 4,727 2024-01-18
0%
20 Walsh Dennis Leo Director 4,727 2024-01-18
0%

No ownership data available for DCPH.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message